Pearsanta acquires patents for adductomics-based DNA damage detection
Aditxt subsidiary Pearsanta has acquired patents associated with adductomics-based DNA damage detection to advance cancer diagnostics. The post Pearsanta acquires patents for adductomics-based DNA damage detection appeared first on Medical Device Network.

The post Pearsanta acquires patents for adductomics-based DNA damage detection appeared first on Medical Device Network.